5 Results for "

CDK12/13-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "CDK12/13-IN-1" in MCE Product Catalog:

Cat. No.: HY-160284
CAS No.: 2407774-31-4
Target:  

CDK

Research Areas:  

Cancer

CDK12/13-IN-1 (Compound 4) is a CDK12/13 inhibitor. CDK12/13-IN-1 has antitumor activity .
loading...
    loading...
Cat. No.: HY-151110
CAS No.: 3025994-75-3
Purity:  98.01%
Target:  

PROTACs CDK

Research Areas:  

Cancer

PROTAC CDK12/13 Degrader-1 (7f) is a highly selective cell cycle protein-dependent kinase CDK12/CDK13 dual degrader with the DC50 values of 2.2 nM and 2.1 nM, respectively. PROTAC CDK12/13 Degrader-1 has anti-proliferative activity and can be used in breast cancer research .
loading...
    loading...
Cat. No.: HY-151110A
Purity:  99.12%
Target:  

PROTACs CDK

Research Areas:  

Cancer

PROTAC CDK12/13 Degrader-1 (7f) TFA is a highly selective cell cycle protein-dependent kinase CDK12/CDK13 dual degrader with the DC50 values of 2.2 nM and 2.1 nM, respectively. PROTAC CDK12/13 Degrader-1 TFA has anti-proliferative activity and can be used in breast cancer research .
loading...
    loading...
Cat. No.: HY-149819
CAS No.: 2944087-54-9
Purity:  99.60%
Target:  

HDAC CDK

Research Areas:  

Cancer

CDK/HDAC-IN-3 is an orally active HDACs/CDKs dual inhibitor. CDK/HDAC-IN-3 has potent and selective inhibition of CDK9, CDK12, CDK13, HDAC1, HDAC2 and HDAC3 with IC50 values of 98.32 nM, 98.85 nM, 100 nM, 62.12 nM, 93.28nM and 82.87 nM. CDK/HDAC-IN-3 can be used for the acute myeloid leukemia (AML) .
loading...
    loading...
Cat. No.: HY-48507
Research Areas:  

Others

CDK12/13 ligand 4 is a CDK12/13 ligand that can be used for the synthesis of PROTACs, such as PROTAC CDK12/13 Degrader-1 (HY-151110) .
loading...
    loading...